Human immunodeficiency virus (HIV) ribonucleic acid (RNA) levels generally remain undetectable in the cerebrospinal fluid of people living with HIV with peripheral viral suppression. Secondary HIV central nervous system (CNS) escape refers to the rare independent replication of HIV RNA in the central nervous system despite peripheral viral suppression that occurs in the setting of a concomitant non-HIV infection. We describe here a young man with perinatal HIV infection considered a viral controller who developed secondary HIV CNS escape in the setting of a presumed fungal CNS infection.
ValcourVChalermchaiTSailasutaN, et al.
Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis2012;
206: 275–282.
2.
EntingRHPrinsJMJurriaansS, et al.
Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection. Clin Infect Dis2002;
32: 1095–1099.
3.
Villar del SazSSuedOFalcoV, et al.
Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up. J Neurovirol2008;
14: 474–479.
4.
TambussiGGoriACapiluppiB, et al.
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis2000;
30: 962–965.
5.
CinquePVagoLCeresaD, et al.
Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS1998;
12: 389–394.
6.
StingeleKHaasJZimmermannT, et al.
Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology2001;
56: 355–361.
7.
EdénAFuchsDHagbergL, et al.
HIV‐1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis2010;
202: 1819–1825.
8.
NightingaleSGerettiAMBeloukasA, et al.
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia. J Neurovirol2016;
22: 852–860.
9.
PelusoMJFerrettiFPetersonJ, et al.
Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS2012;
26: 1765–1774.
10.
FerrettiFGisslenMCinqueP, et al.
Cerebrospinal fluid HIV escape from antiretroviral therapy. Curr HIV/AIDS Rep2015;
12: 280–288.
11.
Rosas-UmbertMLlanoABellidoR, et al.
Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers. J Virol2019;
93: e0143618
12.
DahlVPetersonJSpudichS, et al.
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers. AIDS2013;
27: 1145–1149.
13.
WendelKAMcArthurJC.Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication. Clin Infect Dis2003;
37: 1107–1111.
14.
BeguelinCVazquezMBertschiM, et al.
Viral escape in the CNS with multidrug-resistant HIV-1. J Int AIDS Soc2014;
17: 19745
15.
MangioniDMuscatelloASabbatiniF, et al.
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: worth the risk?Clin Infect Dis2014;
59: 1655–1656.
16.
ImazACayuelaNNiuboJ, et al.
Short communication: focal encephalitis related to viral escape and resistance emergence in cerebrospinal fluid in a patient on lopinavir/ritonavir monotherapy with plasma HIV-1 RNA suppression. AIDS Res Hum Retroviruses2014;
30: 984–987.
17.
BinghamRAhmedNRangiP, et al.
HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int J STD AIDS2011;
22: 608–609.
18.
GrabarSSelinger-LenemanHAbgrallS, et al.
Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV – ANRS CO4. PLoS One2017;
12:
